Natthakarn Mingngamsup

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

National Science and Technology Development Agency(Current)

National Center for Genetic Engineering and Biotechnology

Natthakarn Mingngamsup is an author at National Science and Technology Development Agency specializing in infectious diseases, vaccination, and antibody pharmacokinetics.

Publications per year

2022–2023

Publications

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak et al. · Human Vaccines & Immunotherapeutics · 2022 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers

Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung et al. · Scientific Reports · 2023 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

1–2 of 2